Abnormal mechanical function in diabetes: Relationship to altered myocardial carbohydrate/lipid metabolism

Coronary Artery Disease

Volumn 7, Issue 2, 1996, Pages 116-123

  Lopaschuk, Gary D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

diabetes; fatty acids; glucose; heart

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARNITINE; CARNITINE PALMITOYLTRANSFERASE; CHOLINE; FATTY ACID; GLUCOSE; HYDRALAZINE; INOSITOL; LIOTHYRONINE; METFORMIN; METHIONINE; PROTEIN KINASE; TRIACYLGLYCEROL; VANADIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; CARBOHYDRATE METABOLISM; CARDIOMYOPATHY; DIABETES MELLITUS; ENERGY METABOLISM; EXERCISE; FATTY ACID METABOLISM; GLUCOSE METABOLISM; HEART MUSCLE CONTRACTILITY; HEART MUSCLE METABOLISM; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

EID: 0030017114     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199602000-00004     Document Type: Review

References (124)

1. Bradley RF, Bryfogle JW: Survival of diabetic patients after myocardial infarction. Am J Med 1956, 30:207-216.
2. Kesler I: Mortality experience of diabetic patients: a twenty-six year follow-up study. Am J Med 1971, 51:715-724.
3. Partamian JO, Bradley RF: Acute myocardial infarction in 258 cases of diabetes. N Engl J Med 1965, 273:455-461.
4. Rytter L, Troelsen S, Beck-Nielsen H: Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care 1985, 8:230-234.
5. Ulvenstam G, Aberg A, Bergstrand R, Johansson S, Pennert K, Vedin A, et al.: Long-term prognosis after myocardial infarction in men with diabetes. Diabetes 1985, 34:787-792.
6. Borrow KM, Jaspan JB, Williams KA, Neumann A, Wolinski-Walley P, Lang RM: Myocardial mechanics in young adult patient with diabetes mellitus: effects of altered load, inotropic state and dynamic exercise. JACC 1990, 15:1508-1517.
7. Fein FS, Sonnenblick: Diabetic cardiomyopathy. Prog Cardiovasc Dis 1985, 4:255-270.
8. Hamby RI, Zoneraich, Sherman L: Diabetic cardiomyopathy. JAMA 1974, 229:1749-1754.
9. Ledet T: Diabetic cardiomyopathy: quantitative histological studies of the heart from young juvenile diabetics. Acta Pathol Microbiol Scand 1976, 84:421-428.
10. Mustonen JN, Uusitupa MIJ, Tahvanainen K, Talwar S, Laakso M, Lansimies E, et al.: Impaired left ventricular systolic function during exercise in middle-aged insulin-dependent and noninsulin-dependent diabetic subjects without clinically evident cardiovascular disease. Am J Cardiology 1988, 62:1273-1279.
11. Seneviratne BIB: Diabetic cardiomyopathy: the preclinical phase. BMJ 1977 i:1444-1447.
12. Shapiro LM, Howat AP, Calter MM: Left ventricular function in diabetes mellitus I: Methodology, and prevalence and spectrum of abnormalities. Br Heart J 1981, 45:122-128.
13. Uusitupa M, Mustonen J, Laalso M, Vainio P, Lansimies E, Talwar S, et al.: Impairment of diastolic function in middle-aged Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetic patients free of cardiovascular disease. Oiabetologia 1988, 31:783-791.
14. Vered, Z, Battler A, Segal P, Liberman D, Yerushalmi Y, Berezin M, et al.: Exercise-induced left ventricular dysfunction in young men with asymptomatic diabetes mellitus (diabetic cardiomyopathy). Am J Cardiol 1984, 54:633-637.
15. Kannel WB, McGee DL: Diabetes and cardiovascular risk factors: the Framingham study. Circulation 1979, 59:8-13. This study demonstrated that diabetes was an independent risk factor for the development ol heart disease.
16. Regan TJ, Lyons MM, Ahmed SS, Levmson GE, Oldewurtel HA, Ahmad MR, Haider B: Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 1977, 60:884-899. The presence of a specific cardiomyopathy was described in diabetics. The key results opened up a major area of investigation (i.e. the subcellular mechanisms responsible for development of diabetic cardiomyopathies).
17. Jarrett RJ, McCartney P, Keen H: The Bedford Survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 1982, 22:79-84.
18. Galderisi M, Anderson KM, Wilson PWF, Levy D: Echocardiographic evidence of a distinct diabetic cardiomyopathy. The Framingham Heart Study. Am J Cardiol 1991, 68:85-89.
19. Danielsen R, Nordrehaug JE, Lien RE, Harald VM: Subclinical left ventricular abnormalities in young subjects with long-term diabetes mellitus detected by digitized M-mode echocardiography. Am J Cardiol 1987, 60:143-146.
20. Perez JE, McGill JB, Santiago JV, Schechtman KB, Waggoner AD, Miller JG. et al.: Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease. J Am Coll Cardiol 1992, 19:1154-1162.
21. Hiramtsu K, Ohara N, Shigematsu S, Aizawa T, Ishihara F, Niwa A, et al.: Left venticular filling abnormalities in non-insulin-depenent diabetes mellitus and improvement by a short term glycemic control. Am J Cardiol 1992, 70:1185-1189.
22. Zarich SW, Arbuckle BE, Cohen LR, Robert M, Nesto RW: Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography. J Am Coll Cardiol 1988, 12:114-120.
23. Riggs TW, Transue D: Doppler echocardiographic evaluation of left ventricular diastolic function in adolescents with diabetes mellitus. Am J Cardiol 1990, 65:899-902. The authors demonstrated that abnormalities in left ventricular diastolic function could occur even in adolescents, confirming that direct diabetes-induced changes in the myocardium can contribute to diabetic cardtomyopathies.
24. Celentano A, Vaccaro O, Tammaro P, Galderisi M, Crivaro M, Oliviero M, et al.: Early abnormalities of cardiac funciton in non-insulin-dependent diabetic mellitus and impaired glucose tolerance. Am J Cardiol 1995, 76:1173-1176.
25. Jaffe AS, Spadaro JJ, Schechtman K, Roberts R, Geltman EM, Sobel BE: Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. Am Heart J 1984, 108:31-37.
26. Oswald B, Corcovan S, Yudkin JS: Prevalence and risks of hyperglycemia and undiagnosed diabetes in patients with acute myocardial infarction. Lancet 1984, 1:1264-1267.
27. Oswald GA, Smith CCT, Betteridge DJ, Yudkin JS: Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. BMJ 1986, 293:917-922.
28. Bellodi G, Manicardi V, Malavasi V, Venen L, Bernini G, Bossini P, et al.: Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 1989, 64:885-888.
29. Miller TB: Cardiac performance of isolated perfused heart from alloxan diabetic rats. Am J Physiol 1972, 236:H808-H812. This study provided some of the first experimental evidence that cardiac dysfunction could occur in experimental models of diabetes
30. Penpargkul S, Schaible TF, Yipintsoi T, Scheuer J: The effect of diabetes on performance and metabolism of rat hearts. Circ Res 1980, 47:911-921.
31. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Brauwood AW, Grishman AA: A new type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972, 30:595-602.
32. Shapiro LM: Specific heart disease in diabetes mellitus. BMJ 1982, 284:140-141
33. Tahiliani AG, McNeill JH: Diabetes-induced abnormalities in the myocardium. Lite Sci 1986, 38:959-974.
34. Tomlinson KC, Gardiner SM, Hebden RA, Bennett T: Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Reviews 1992, 44:103-150.
35. Paulson DJ, Shug AL, Jurak R, Schmidt M: The role of altered lipid metabolism in the cardiac dysfunction associated with diabetes. In The Diabetic Heart, Edited by Nagano M, Dhalla NS. New York: Raven Press, 1991:395-407.
36. Dhalla NS, Pierce GN, Innes IR, Beamish RE: Pathogenesis of cardiac dysfunction in diabetes mellitus. Can J Cardiol 1985, 1:263-281.
37. Kereiakes DJ, Naughton JL, Brudnage B, Schiller NB: The heart in diabetes. Western J Med 1984, 140:583-593.
38. Lopaschuk GD: Alterations in myocardial fatty acid metabolism contribute to ischemic injury in the diabetic. Can J Cardiol 1989, 5:315-320.
39. Neely JR, Morgan HE: Relationship between carbohydrate metabolism and energy balance of heart muscle. Annu Rev Physiol 1974, 36:413-459. This is a thorough and excellent review of the relationship between carbohydrate and fatty acid metabolism in the heart. Despite being written over 20 years ago, it is required reading for an understanding of how energy metabolism is regulated in the heart.
40. Bing RJ: Cardiac metabolism. Physiol Rev 1964, 45:171-213. This classic review described energy substrate preference by the heart. The paper also overviewed the early studies performed by Bing which unequivocally demonstrated that fatty acids are the preferred fuel of the heart.
41. Goodale WT, Hackel DB: Myocardial carbohydrate metabolism in normal dogs, with effects of hyperglycemia and starvation. Circ Res 1953, 1:509-517
42. Opie LH: Metabolism of the heart in health and disease. Am Heart J 1968, 76:685-689. The relationship between alterations in myocardial energy metabolism and heart disease is highlighted in this excellent review.
43. Saddik M, Lopaschuk GD: Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J Biol Chem 1991, 266:8162-8170.
44. Garland PB, Randle PJ: Regulation of glucose uptake by muscle. X. Effects of alloxan-diabetes, starvation, hypophysectomy and adrenalectomy and of fatty acids, ketone bodies and pyruvate on the glycerol output and concentrations of free fatty acids, long-chain fatty acyl coenzyme A, glycerol phosphate and citrate cycle intermediates in rat hearts and diaphragm muscles. Biochem J 1964, 93:678-687. A classic study defined the changes in fatty acid metabolism that occur in muscle from diabetic rats. The authors also give important insights into the way in which fatty acid metabolism is regulated.
45. Randle PJ: Fuel selection in animals. Biochem Soc Trans 1986, 14:799-806.
46. Goodale WT, Olson RE, Hackel DB: The effects of fasting and diabetes mellitus on myocardial metabolism in man. Am J Med 1959, 212-220.
47. Wall SR, Lopaschuk GD Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic rat Biochim Biophys Acta 1989, 1006:97-103.
48. Randle PJ, Newsholme EA, Garland PB: Regulation of glucose uptake by muscle: effects of fatty acids, ketone bodies and pyruvate and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles. Biochem J 1993, 93:652-665.
49. Randle PJ, Hales CN, Garland PB, Newsholme EA: The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetic mellitus. Lancet 1963, i:785-789. Yet another classic study defined the glucose fatty-acid cycle. The now famous Randle Cycle defined the key sites at which fatty acids alter glucose metabolism in muscle.
50. Newsholme EA, Randle PJ, Manchester KL: Inhibition of the phosphofructokinase reaction in perfused rat hearts by respiration of ketone bodies, fatty acids and pyruvate. Nature 1962, 193:270-271. The authors showed how glycolysis can be altered by fatty acids. Citrate inhibition of phosphofructokinase was shown to be a key factor.
51. Kerbey AL, Vary TC, Randle PJ: Molecular mechanism regulating myocardial glucose oxidation. Basic Res Cardiol 1985, 80 (suppl 2):93-96.
52. Randle PJ, Priestman DA, Mistry S, Halsall: Mechanisms modifying glucose oxidation in diabetes mellitus. Diabetologia 1994, 37 (suppl 2):S155-S161.
53. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YI: Measurements of plasma glucose, free fatty acid, lactate, and insulin for 24h In patients with NIDDM. Diabetes 1988, 37:1020-1024.
54. Fraze E, Donner CC, Swislocki ALM, Chiou Y-AM, Chen Y-DI, Revean GM: Ambient plasma free fatty acid concentration in noninsulin-dependent diabetes mellitus. J Clin Endocrinol 1985, 61:807-811.
55. Saddik M, Lopaschuk GD: Triacylglycerol turnover in isolated working hearts of acutely diabetic rats. Can J Physiol Pharmacot 1994, 72:1110-1119.
56. Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schönekess BO: Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1994, 1213:263-276
57. Ballard FB, Danforth WH, Naegle S, Bing RJ: Myocardial metabolism of fatty acids. J Clin Invest 1960, 39:717-723.
58. Evans JR, Hollenberg CH: Lipid metabolism in the diabetic rat heart J Clin Invest 1964, 43:1234.
59. Denton RM, Randle PJ: Concentration of glycerides and phospholipids in rat heart and gastrocnemius muscles. Biochem J 1967, 104:416-422.
60. Murthy VK, Shipp JC: Accumulation of myocardial triacylglycerols in ketotic diabetes. Diabetes 1977, 26:222-229.
61. Rizza RA, Crass MF, Shipp JC: Effect of insulin treatment in vivo on heart glycerides and glycogen of alloxan-diabetic rats. Metabolism 1974, 20:539-543.
62. Murthy VK, Bauman MD, Shipp JC: Regulation of triacylglycerol lipolysis in the perfused hearts of normal and diabetic rats. Diabetes 1983, 32:718-722.
63. Lopaschuk GD, Tsang H: Metabolism of palmitate in isolated working hearts from spontaneously diabetic 'BB' Wistar rats. Circ Res 1987, 61:853-858.
64. Gamble J, Lopaschuk GD: Glycolysis and glucose oxidation during reperfusion of ischemic hearts from diabetic rats. Biochim Biophys Acta 1994, 1225:191-199.
65. McGarry JD, Woeltje KF, Kuwajima M, Foster DW: Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase. Diabetes 1989, 5:271-284.
66. Cook GA, Lappi MD: Carnitine palmitoyltransferase in the heart is controlled by a different mechanism than the hepatic enzyme. Mol Cell Biochem 1992, 116:39-45.
67. Saddik M, Gamble J, Witters LA, Lopaschuk GD: Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J Biol Chem 1993, 268:25836-25845. Acetyl CoA carboxylase was shown to be important in regulating fatty acid oxidation in the heart.
68. Gamble J, Witters LA, Lopachuk, GD: Differential tissue of expression of acetyl CoA carboxylase (ACC) in diabetes [abstract]. Can J Cardiol 1994, 10:68C.
69. Gamble J, Makinde AO, Russel J, Lopaschuk GG: Heart AMP-activate protein kinase activity in insulin-resistant rats. J Mol Cell Cardiol 1995, 27:A34.
70. Garvey WT, Hardin D, Juhaszova M, Dominguez JH: Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy. Am J Physiol 1993, 264:H837-H844.
71. Avogaro A, Nosadini R, Doria A, Fioretto P, Velussi M, Vigonto C, et al.: Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease. Am J Physiol 1990, 258:E606-E618.
72. Penpargkul S, Schaible T, Yipintsoi T, Scheuer J: The effect of diabetes on performance and metabolism of rat hearts. Cire Res 1980, 47:911-921.
73. Barrett EJ, Schwartz RG, Francis CK, Zaret BL: Regulation by insulin of myocardial glucose and fatty acid metabolism in the conscious dog. J Clin Invest 1984, 74:1073-1079.
74. Camps MA, Castello P, Munoz M, Monfar X, Testar M, Palacin A, et al.: Effect of diabetes and fasting on GLUT-4 (muscle-fat) glucose-transporter expression in insulin-sensitive tissues. Biochem J 1992, 282:765-772.
75. Stanley WC, Hernandez LA, Spires DA, Bringas J, Wallace S, McCormack JG: Pyruvate dehydrogenase activity and malonyl CoA levels in normal and ischemic swine myocardium: effects of dichloroacetate. (in press).
76. Kainulainen H, Schurmann A, Vilja P, Joost HG: In vivo glucose uptake and glucose transporter proteins GLUT1 and GLUT3 in brain tissue from streptozotocin-diabetic rats. Acta Physiol Scand 1993, 149:221-225.
77. Kraegen EW, Sowden JA, Halstead MB, Clark PW, Rodnick KJ, Chisholm DJ, et al.: Glucose transporters and in vivo glucose uptake In skeletal and cardiac muscle: fasting, insulin stimulation and Immunoisolation studies of GLUT1 and GLUT4. Biochem J 1993, 295:287-293.
78. Chen V, lanuzzo CD, Fong BC, Spitzer JJ: The effects of acute and chronic diabetes on myocardial metabolism in rats. Diabetes 1984, 33:1078-1084.
79. 13C-NMR study of glucose oxidation in the intact functioning rat heart following diabetes induced cardiomyopathy. J Mol Cell Cardiol 1994, 25:1203-1213.
80. Stanley WC, Hall JL, Smith KR, Cartee GD, Hacker TA, Wisneski JA: Myocardial glucose transporters and glycolytic metabolism during ischemia in hyperglycemic diabetic swine. Metabolism 1994, 43:61-69.
81. Wieland O, Siess E, Shulze-Wethmar FH, Funcke HG, Winton B: Active and inactive forms of pyruvate dehydrogenase In rat heart and kidney: effect of diabetes, fasting and refeedlng on pyruvate dehydrogenase interconversion. Arch Biochem Biophys 1971, 143:593-601.
82. Hutson NJ, Kerbey AL, Randle PJ, Sugden PH: Conversion of inactive (phosphorylated) pyruvate dehydrogenase complex into active complex by the phosphate reaction in heart mitochondria is inhibited by alloxan-diabetes or starvation in the rat Biochem J 1978, 173:669-680.
83. Kerbey AL, Randle PJ, Cooper RH, Whitehouse S, Pask HT, Denton RM: Regulation of pyruvate dehydrogenase. Biochem J 1976, 154:327-348.
84. Ohlen J, Siess EA, Loffler G, Wieland OH: The effect of insulin on pyruvate dehydrogenase interconverstion in heart muscle of alloxian-diabetic rats. Diabetologia 1978, 14:135-139.
85. Kuo T, Giacomelli F, Wiener J, Lapanowsi-Netzel K: Pyruvate dehydrogenase activity in cardiac mitochondria from genetically diabetic mice. Diabetes 1985, 34:1075-1081.
86. Wieland O, Funcke HV, Loffler G. Interconversion of pyruvate dehydrogenase in rat heart muscle upon perfusion with fatty acids or ketone bodies. FEBS Lett 1971, 15:295-298
87. Broderick T, Barr RL, Quinney A, Lopaschuk GD: Acute insulin withdrawal from diabetic BB rats decreases myocardial glycolysis during low-flow ischemia. Metabolism 1992, 41:33-338.
88. Lopaschuk GD, Wall SR, Olley PM, Davies NJ: Etomoxir, a camitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced injury independent of changes in long chain acylcarnitine. Circ Res 1988, 63:1036-1043.
89. Lopaschuk GD, Saddik M, Barr R, Huang L, Barker CC, Muzyka RA: Effects of high levels of fatty acids on functional recovery of ischemic hearts from diabetic rats. Am J Physiol 1992, 263:E1046-E1053.
90. Lopaschuk GD, Spafford M: Acute insulin withdrawal contributes to ischemic heart failure in spontaneously diabetic BB Wistar rats. Can J Physiol Pharmacol 1990, 68:462-66.
91. 2+ myosin ATPase activity and changes myosin isoenzyme distribution In the diabetic rat heart. Am J Physiol 1985, 248:E602-E605. This was one of the first studies to demonstrate that pharmacological modification of fatty acid metabolism can reverse some of the biochemical changes that occur in the diabetic heart.
92. 2+ activated myosin ATPase activity in the rat heart Influenced by fructose feeding and triiodothyronine. Endocrinology 1985, 16:2160-2166
93. Hekimian G, Feuvray D: Reduction of ischemia-induced acyl camitine accumulation by TDGA and its influence on lactate dehydrogenase release in diabetic rat hearts. Diabetes 1986, 35:906-910.
94. Rösen P, Herberg L, Reinauer H: Different types of postinsulin receptor defects contribute to insulin resistance In hearts of obese Zucker rats. Endocrinology 1986, 119:1285-1291.
95. Rupp H, Wahl R, Hansen M: Influence of diet and carnitine palmitoyltransferase I Inhibition on myosin and sarcoplasmic reticulum. J Appl Physiol 1992, 72:352-360.
96. Rösen P, Reinauer H: Inhibition of carnitine palmitoyltransferase 1 by phenylalkyloxiranecarboxylic acid and its influence on lipolysis and glucose metabolism in isolated, perfused hearts of streptozotocin-diabetic rats. Metabolism 1984, 22:177-185.
97. Pieper GM, Murray WJ, Salhany JM, Wu ST, Elio RS: Salient effects of L-carnrtine on adenine-nucleotide loss and coenzyme A acylation in the diabetic heat perfused with excess palmitic acid. Biochim Biophys Acta 1984, 803:241-249.
98. Broderick T, Quinney HA, Lopaschuk GD: L-carnitine increases glucose metabolism and mechanical function following ischaemia in diabetic rat heart Cardiovasc Res 1995, 29:373-378
99. Nicholl TA, Lopaschuk GD, McNeill JH: Effects of free fatty acids and dlchloroacetate on isolated working diabetic rat heart Am J Physiol 1991, 261:1053-1059.
100. Lopaschuk GD, Spaftord M: Response of isolated working hearts from acutely and chronically diabetic rats to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow. Cire Res 1989, 65:378-387.
101. Rodngues B, Xiang H, McNeill JH: Effect of L-carnrtine treatment on lipid metabolism and cardiac performance in chronically diabetic rats. Diabetes 1988, 37:1358-1364.
102. 3 on myocardial lipids and cardiac function in streptozotocin diabetc rats. Diabetes 1988, 37:1542-1548.
103. Burns AH, Racey Burns LA, Jurenka LU, Summer WR: Myocardial metabolic effects of in vivo hydralazine treatment of streptozotocindaibetic rats. Am J Physiol 1991, 260:H516-H521.
104. Rodrigues G, Goyal RK, McNeill JH: Effects of hydralazine on streptozotocin-induced diabetic rats: prevention of hyperlipidemia and Improvement of cardiac function. J Pharmacol Exp Ther 1986, 237:292-299.
105. Heyliget CE, Rodnques B, McNeill JH: Effect of choline an methionine treatment on cardiac dysfunction of diabetic rats. Diabetes 1988, 35:1152-1157.
106. Heyliger CE, Tahiliani AG, McNeill JH: Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 1985, 227:1474-1476. These authors made the important observation that vanadate can lower blood glucose in diabetic rat. Their Undings provided the basis tor a number of subsequent studies showing how vanadate mimics the effects of insulin on tyrosine phosphorylation.
107. Foley JF: Rationale and application of fatty acid oxidation inhibitors in treatment of diabetes mellrtus. Diabetes Care 1993, 5:773-784
108. Verma S, McNeill JH: Metformin improves cardiac function in isolated streptozotocin-dalbetic rat hearts. Am J Physiol 1994, 266:H714-H719.
109. Paulson DJ, Kopp SJ, Peace DG, Tow JP: Myocardial adaptation to endurance exercise training in diabetic rats. Am J Physiol 1987, 252:R1073-R1081.
110. Tan MH, Bonen A, Gamer JB, Belcastro AN: Physical training in diabetic rats: effects on glucose tolerance and serum lipids. J Appl Physiol 1982, 52:1514-1518.
111. Paulson DJ, Mathews R, Bowman J, Zhao J: Metabolic effects of treadmill exercise training on the diabetic heart. J Appl Physiol. 1992, 73:265-271
112. Schönekess BO, Allard MF, Lopaschuk GD: Propionyl L-carnitine improvement of hypertrophied heart function is accompanied by an increase in carbohydrate oxidation. Circ Res 1995, 77:726-734.
113. Broderick TL, Quinney H, Lopaschuk GD: Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart. J Biol Chem 1992, 267:3758-3763.
114. Broderick TL, Quinney HA, Barker CC, Lopaschuk GD: The beneficial effect of carnitine on mechanical recovery of rat hearts reperfused after a transient period of global ischemia is accompanied by a stimulation of glucose oxidation. Circulation 1994, 87:972-981.
115. Feuvray D, Idell-Wenger JA, Neely JR: Effects of ischemia on rat myocardial function and metabolism in diabetes. Circ Res 1979, 44:322-329.
116. Fogle PJ, Bieber LL: Effect of streptozotocin on carnitine and camitine acyltransferases in rat heart, liver, and kidney. Biochem Med 1976, 22:119-126.
117. Pearson DJ, Tubbs PK: Camitine and derivatives in rat tissues. Biochem J 1967, 105:953-963.
118. Vary TC, Neely JR: A mechanism for reduced myocardial carnitine levels in diabetic animals. Am J Physiol 1982, 243:H154-H15B.
119. Paulson DJ, Schmidt MJ, Traxler JS, Ramacci MT, Shug AL: Improvement of myocardial function in diabetic rats after treatment with L-camltine. Metabolism 1984, 33:358-363.
120. Folts JD, Shug AL, Koke JR, Bittar N: Protection of the ischemic dog myocardium with carnitine. Am J Cardiol 1978, 41:1209-1215.
121. Liedtke AJ, Nellis SH: Effects of carnitine in ischemic and fatty acid supplemented swine hearts. J Clin Invest 1979, 64: 440-447.
122. Liedtke AJ, Nellis SH, Whitesell LF, Mahar CQ: Metabolic and mechanical effects using L- and D-carnitine in working swine hearts. Am J Physiol 1982, 243: H691-H697.
123. Ichahara K, Neely JR: Recovery of ventricular function in reperfused ischemic hearts exposed to fatty acids. Am J Physiol 1985, 249:H492-H497.
124. Lysiak W, Toth PP, Suelter CH, Bieber LL: Quantification of the effect of L-carnitine on the levels of acid-soluble short-chain acyl CoA and CoASH in rat heart and liver mitochondria. J Biol Chem 1988, 263:1511-1156.